Literature DB >> 2303730

Purification and properties of peritoneal eosinophils from pediatric dialysis patients.

R L Roberts1, B J Ank, I B Salusky, E R Stiehm.   

Abstract

Peritoneal eosinophilia frequently occurs in patients undergoing peritoneal dialysis. We have devised a method for isolating large numbers of these peritoneal eosinophils from pediatric patients on continuous peritoneal dialysis. Patients were selected on the basis of previous high peritoneal eosinophil counts and had an age range of 1.5-11 years. The unfractionated peritoneal fluid contained 7.9 +/- 3.7% neutrophils, 3.8 +/- 1.0% lymphocytes, 11.0 +/- 3.7% monocytes/macrophages, and 77.3 +/- 6.3% eosinophils (based on Wright stain) and up to 2 x 10(9) cells could be recovered from 1 liter of peritoneal dialysate. The cells were concentrated by centrifugation and the cell suspension then layered over a discontinuous Percoll gradient consisting of layers of 45%, 55%, 65%, and 75% Percoll. The gradients were centrifuged resulting in the formation of bands of cells at the interfaces of the layers. The densest band of cells (above 75% Percoll) contained 94.7 +/- 1.8% eosinophils (mean with median of 98%) and 4.3 +/- 16% neutrophils. The eosinophil counts were 72.2 +/- 7.1% above the 65% layer, 57.1 +/- 8.7 above 55%, and 40.9 +/- 10.9% above 45%. The monocyte/macrophage count increased from 0.1% above the 75% layer to 42.9% above the 45%. The denser eosinophils (above 75% and 65%) had the appearance of normal blood eosinophils and comparable function to blood eosinophils in cytotoxic and oxidative assays. This method provides a means of obtaining large numbers of very pure eosinophils for study of eosinophil function, eosinophil subpopulations, or eosinophil granule constituents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303730     DOI: 10.1016/0022-1759(90)90152-l

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

Review 1.  Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.

Authors:  D R Lucey; M Clerici; G M Shearer
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

2.  Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines.

Authors:  E R Stiehm; R L Roberts; B J Ank; S Plaeger-Marshall; N Salman; L Shen; M W Fanger
Journal:  Clin Diagn Lab Immunol       Date:  1994-05

3.  Role of oxygen intermediates in cytotoxicity: studies in chronic granulomatous disease.

Authors:  R L Roberts; B J Ank; M W Fanger; L Shen; E R Stiehm
Journal:  Inflammation       Date:  1993-02       Impact factor: 4.092

4.  Human eosinophils as antigen-presenting cells: relative efficiency for superantigen- and antigen-induced CD4+ T-cell proliferation.

Authors:  S D Mawhorter; J W Kazura; W H Boom
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

5.  Class II major histocompatibility complex molecule expression on murine eosinophils activated in vivo by Brugia malayi.

Authors:  S D Mawhorter; E Pearlman; J W Kazura; W H Boom
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

Review 6.  Ontogeny of myeloid cells.

Authors:  Ismé De Kleer; Fabienne Willems; Bart Lambrecht; Stanislas Goriely
Journal:  Front Immunol       Date:  2014-09-03       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.